Conatus Pharmaceuticals Inc (NASDAQ:CNAT) was the recipient of a large growth in short interest in January. As of March 14th, there was short interest totalling 985,400 shares, a growth of 82.6% from the February 28th total of 539,790 shares, Analyst Ratings News reports. Conatus Pharmaceuticals Inc (NASDAQ:CNAT) stock performance was -6.33% in last session and finished the day at $7.10. Traded volume was 378,401.00million shares … Continue reading Biotech Bearish Stocks: Conatus Pharmaceuticals Inc (NASDAQ:CNAT), Kindred Biosciences (NASDAQ:KIN), BIND Therapeutics (NASDAQ:BIND), Aratana Therapeutics (NASDAQ:PETX)